Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastric Emptying and Insulin Timing in T1DM
NCT06173934Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of human insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Characteristics of gastric emptying (the gastric half-emptying time) at Day 7. Started Dec 2023; status: recruiting.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06173934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06173934.